NASDAQ: BIIB - Biogen

Yield per half year: -28.12%
Dividend yield: 0.00%
Sector: Healthcare

Current price
139.16 $
Average price
165.27 $ +18.76%

Average analyst price
241.7 $ +73.68%
Price based on EPS
110.17 $ -20.83%
Price according to DCF model (ebitda)
70.41 $ -49.4%
Discount price Net Income
64.38 $ -53.74%
4/10
270.00270.00240.00240.00210.00210.00180.00180.00150.00150.00120.00120.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Average analyst price

Fair price = 241.7 $
Current price = 139.16 $ (difference = +73.68%)

IdeaPrice forecastChangesExpiration dateAnalyst
Biogen: возьмем на память 241.7 $ +102.54 $ (73.68%) 11.09.2025 Финам
241.773.68

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 110.17 $
Current price = 139.16 $ (difference = -20.83%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 70.41 $
Current price = 139.16 $ (difference = -49.4%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 339.69 $
Current price = 139.16 $ (difference = +144.1%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription